276 related articles for article (PubMed ID: 24861491)
21. Surgical treatment of intractable epilepsy associated with focal cortical dysplasia.
Diaz RJ; Sherman EM; Hader WJ
Neurosurg Focus; 2008 Sep; 25(3):E6. PubMed ID: 18759630
[TBL] [Abstract][Full Text] [Related]
22. Brain somatic mutations in MTOR leading to focal cortical dysplasia.
Lim JS; Lee JH
BMB Rep; 2016 Feb; 49(2):71-2. PubMed ID: 26779999
[TBL] [Abstract][Full Text] [Related]
23. NPRL3 loss alters neuronal morphology, mTOR localization, cortical lamination and seizure threshold.
Iffland PH; Everett ME; Cobb-Pitstick KM; Bowser LE; Barnes AE; Babus JK; Romanowski AJ; Baybis M; Elziny S; Puffenberger EG; Gonzaga-Jauregui C; Poulopoulos A; Carson VJ; Crino PB
Brain; 2022 Nov; 145(11):3872-3885. PubMed ID: 35136953
[TBL] [Abstract][Full Text] [Related]
24. Organization of the epileptogenic zone and signal analysis at seizure onset in patients with drug-resistant epilepsy due to focal cortical dysplasia with mTOR pathway gene mutations-An SEEG study.
Oane I; Barborica A; Daneasa A; Maliia MD; Ciurea J; Stoica S; Dabu A; Bratu F; Lentoiu C; Mindruta I
Epilepsia Open; 2023 Dec; 8(4):1588-1595. PubMed ID: 37574648
[TBL] [Abstract][Full Text] [Related]
25. mTOR inhibitors as a new therapeutic option for epilepsy.
Curatolo P; Moavero R
Expert Rev Neurother; 2013 Jun; 13(6):627-38. PubMed ID: 23739000
[TBL] [Abstract][Full Text] [Related]
26. Focal cortical dysplasia pathology: diagnostic difficulty, classification, and utility for pathogenesis.
Kapar O; Gurkan ZM; Dolgun M; Sencer A; Gürses C; Bilgic B
Neurosurg Focus; 2022 Oct; 53(4):E6. PubMed ID: 36183176
[TBL] [Abstract][Full Text] [Related]
27. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.
Wong M
Epilepsia; 2010 Jan; 51(1):27-36. PubMed ID: 19817806
[TBL] [Abstract][Full Text] [Related]
28. Age at epilepsy onset in patients with focal cortical dysplasias, gangliogliomas and dysembryoplastic neuroepithelial tumours.
Rácz A; Müller AM; Schwerdt J; Becker A; Vatter H; Elger CE
Seizure; 2018 May; 58():82-89. PubMed ID: 29677585
[TBL] [Abstract][Full Text] [Related]
29. Anti-seizure gene therapy for focal cortical dysplasia.
Almacellas Barbanoj A; Graham RT; Maffei B; Carpenter JC; Leite M; Hoke J; Hardjo F; Scott-Solache J; Chimonides C; Schorge S; Kullmann DM; Magloire V; Lignani G
Brain; 2024 Feb; 147(2):542-553. PubMed ID: 38100333
[TBL] [Abstract][Full Text] [Related]
30. Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy.
Marsan E; Baulac S
Neuropathol Appl Neurobiol; 2018 Feb; 44(1):6-17. PubMed ID: 29359340
[TBL] [Abstract][Full Text] [Related]
31. Focal Cortical Dysplasia.
Crino PB
Semin Neurol; 2015 Jun; 35(3):201-8. PubMed ID: 26060899
[TBL] [Abstract][Full Text] [Related]
32. Focal brain malformations: seizures, signaling, sequencing.
Crino PB
Epilepsia; 2009 Oct; 50 Suppl 9():3-8. PubMed ID: 19761448
[TBL] [Abstract][Full Text] [Related]
33. Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb.
Nakashima M; Saitsu H; Takei N; Tohyama J; Kato M; Kitaura H; Shiina M; Shirozu H; Masuda H; Watanabe K; Ohba C; Tsurusaki Y; Miyake N; Zheng Y; Sato T; Takebayashi H; Ogata K; Kameyama S; Kakita A; Matsumoto N
Ann Neurol; 2015 Sep; 78(3):375-86. PubMed ID: 26018084
[TBL] [Abstract][Full Text] [Related]
34. Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target.
Galanopoulou AS; Gorter JA; Cepeda C
Epilepsia; 2012 Jul; 53(7):1119-30. PubMed ID: 22578218
[TBL] [Abstract][Full Text] [Related]
35. Balloon cells promote immune system activation in focal cortical dysplasia type 2b.
Zimmer TS; Broekaart DWM; Luinenburg M; Mijnsbergen C; Anink JJ; Sim NS; Michailidou I; Jansen FE; van Rijen PC; Lee JH; François L; van Eyll J; Dedeurwaerdere S; van Vliet EA; Mühlebner A; Mills JD; Aronica E
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):826-839. PubMed ID: 34003514
[TBL] [Abstract][Full Text] [Related]
36. mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia.
Nguyen LH; Brewster AL; Clark ME; Regnier-Golanov A; Sunnen CN; Patil VV; D'Arcangelo G; Anderson AE
Epilepsia; 2015 Apr; 56(4):636-46. PubMed ID: 25752454
[TBL] [Abstract][Full Text] [Related]
37. Genomic DNA methylation distinguishes subtypes of human focal cortical dysplasia.
Kobow K; Ziemann M; Kaipananickal H; Khurana I; Mühlebner A; Feucht M; Hainfellner JA; Czech T; Aronica E; Pieper T; Holthausen H; Kudernatsch M; Hamer H; Kasper BS; Rössler K; Conti V; Guerrini R; Coras R; Blümcke I; El-Osta A; Kaspi A
Epilepsia; 2019 Jun; 60(6):1091-1103. PubMed ID: 31074842
[TBL] [Abstract][Full Text] [Related]
38. Detection of brain somatic variation in epilepsy-associated developmental lesions.
Bedrosian TA; Miller KE; Grischow OE; Schieffer KM; LaHaye S; Yoon H; Miller AR; Navarro J; Westfall J; Leraas K; Choi S; Williamson R; Fitch J; Kelly BJ; White P; Lee K; McGrath S; Cottrell CE; Magrini V; Leonard J; Pindrik J; Shaikhouni A; Boué DR; Thomas DL; Pierson CR; Wilson RK; Ostendorf AP; Mardis ER; Koboldt DC
Epilepsia; 2022 Aug; 63(8):1981-1997. PubMed ID: 35687047
[TBL] [Abstract][Full Text] [Related]
39. Focal cortical dysplasia: a practical guide for neurologists.
Balestrini S; Barba C; Thom M; Guerrini R
Pract Neurol; 2023 Aug; 23(4):293-302. PubMed ID: 36823117
[TBL] [Abstract][Full Text] [Related]
40. Genotype-phenotype correlations in focal malformations of cortical development: a pathway to integrated pathological diagnosis in epilepsy surgery.
Benova B; Jacques TS
Brain Pathol; 2019 Jul; 29(4):473-484. PubMed ID: 30485578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
